Stéphan Vagner mainly investigates Cell biology, Internal ribosome entry site, Genetics, Initiation factor and Eukaryotic initiation factor. His Cell biology study incorporates themes from RNA splicing and Intron. His RNA splicing study combines topics from a wide range of disciplines, such as Ribonucleoprotein and Polyadenylation.
He mostly deals with RNA in his studies of Genetics. Stéphan Vagner has researched Initiation factor in several fields, including Five prime untranslated region, Ribosome profiling, EIF4E and Eukaryotic translation. His work investigates the relationship between Molecular biology and topics such as Messenger RNA that intersect with problems in Vemurafenib and Cancer research.
His scientific interests lie mostly in Cell biology, Cancer research, Molecular biology, Genetics and RNA splicing. The Cell biology study combines topics in areas such as Polyadenylation, Messenger RNA, RNA-binding protein, Translation and Regulation of gene expression. His Cancer research study combines topics in areas such as Cancer cell, Cancer, Eukaryotic initiation factor 4F and EIF4G.
His study in Molecular biology is interdisciplinary in nature, drawing from both Translational regulation, Internal ribosome entry site, Polypyrimidine tract-binding protein and Intron. His Internal ribosome entry site research is multidisciplinary, relying on both Virology, Five prime untranslated region, Ribosome profiling, Eukaryotic translation and Eukaryotic initiation factor. Stéphan Vagner interconnects Ribonucleoprotein and Alternative splicing, Exon in the investigation of issues within RNA splicing.
Stéphan Vagner spends much of his time researching Cancer research, Cancer, Immunotherapy, eIF4A and Cell biology. The study incorporates disciplines such as Cancer cell, Epigenetics, Cancer treatment and Cancer drugs in addition to Cancer research. His studies in Cancer integrate themes in fields like Gene silencing, EIF4G and Translation initiation complex.
His research integrates issues of Regulation of gene expression, Transcription factor and Untranslated region in his study of eIF4A. In his study, Messenger RNA is inextricably linked to DNA damage, which falls within the broad field of Cell biology. His study in the field of Eukaryotic translation also crosses realms of STAT protein.
His primary areas of study are Cell culture, eIF4A, Immunotherapy, Biochemistry and Glutathione. Stéphan Vagner has included themes like Protein biosynthesis, Translation, Eukaryotic initiation factor 4F, Untranslated region and Cell biology in his Cell culture study. His work deals with themes such as Transcription factor, Regulation of gene expression, Downregulation and upregulation and Cancer research, which intersect with eIF4A.
His work carried out in the field of Immunotherapy brings together such families of science as Eukaryotic translation, Messenger RNA and STAT1. His work on Peroxiredoxin 1, Oxidative stress and Intracellular as part of general Biochemistry research is frequently linked to Dehydroascorbic acid and Cytotoxicity, thereby connecting diverse disciplines of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Chong Sun;Liqin Wang;Sidong Huang;Guus J. J. E. Heynen.
Molecular mechanisms of eukaryotic pre-mRNA 3′ end processing regulation
Stefania Millevoi;Stéphan Vagner.
Nucleic Acids Research (2010)
Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes.
S Vagner;M C Gensac;A Maret;F Bayard.
Molecular and Cellular Biology (1995)
Irresistible IRES. Attracting the translation machinery to internal ribosome entry sites.
Stéphan Vagner;Bruno Galy;Stéphane Pyronnet.
EMBO Reports (2001)
Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site
Cécile Nanbru;Cécile Nanbru;Isabelle I. Lafon;Sylvie S. Audigier;Marie-Claire M.-C. Gensac.
Journal of Biological Chemistry (1997)
Generation of protein isoform diversity by alternative initiation of translation at non-AUG codons.
Christian Touriol;Stéphanie Bornes;Sophie Bonnal;Sylvie Audigier.
Biology of the Cell (2003)
Widespread Estrogen-Dependent Repression of microRNAs Involved in Breast Tumor Cell Growth
Gérard Maillot;Magali Lacroix-Triki;Sandra Pierredon;Lise Gratadou.
Cancer Research (2009)
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies
Lise Boussemart;Hélène Malka-Mahieu;Isabelle Girault;Delphine Allard.
A New 34-Kilodalton Isoform of Human Fibroblast Growth Factor 2 Is Cap Dependently Synthesized by Using a Non-AUG Start Codon and Behaves as a Survival Factor
Emmanuelle Arnaud;Christian Touriol;Christel Boutonnet;Marie-Claire Gensac.
Molecular and Cellular Biology (1999)
G‐quadruplexes in RNA biology
Stefania Millevoi;Hervé Moine;Stéphan Vagner.
Wiley Interdisciplinary Reviews - Rna (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: